This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during October 2024 (epidemiological weeks 40-44). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during September 2024 (epidemiological weeks 36-39). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during August 2024 (epidemiological weeks 32-35). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2024 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during June 2024 (epidemiological weeks 23-26). The data is dependent on submission of samples by clinicians and therefore may not be...
Since May 2022, more than 97 000 cases of mpox have been reported globally from 117 countries, with 186 deaths (as of 31 May 2024). Between June and September of 2022, five cases of mpox were reported in South Africa, with no fatalities. All of these cases reported...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during May 2024 (epidemiological weeks 18-22). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2024 (epidemiological weeks 14-17). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2024 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and B continued to be detected at low rates during February (≤ 5%). RSV detection rates increased from 4% to 8% during the reporting period but did not reach the threshold for the start of RSV...